Yonezawa K
Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Hokkaido Igaku Zasshi. 1991 Jul;66(4):458-67.
Anaerobic threshold (AT) has been advocated as an objective method of evaluating exercise capacity in patients with chronic congestive heart failure. The factors that determine AT, however, remain still unclear. To assess the influence of oxygen transport capacity on AT, patients with iron deficiency anemia were studied before and after treatment with iron. Twenty-nine female subjects were studied. They were divided into the following 3 groups: 1) iron deficiency anemia (group IDA: Hgb less than 11 g/dl and ferritin less than 10 ng/ml) consisting of 4 athletes and 6 non-athletes, 2) latent iron deficiency (group Lat-ID: Hgb greater than or equal to 11 g/dl and ferritin less than 10 ng/ml) consisting of 4 athletes, and normal (group Nor: Hgb greater than or equal to 11 g/dl and ferritin greater than or equal to 10 ng/ml) consisting of 15 athletes and 6 non-athletes. By bicycle ergometer using ramp protocol, peak oxygen uptake (peak VO2) and AT were measured in each group. Following the 1st exercise testing, groups IDA and Lat-ID were treated by oral iron for 1-1.5 months. The 2nd exercise testing was then performed. Furthermore, to investigate whether muscle cell energy metabolism itself is altered by iron deficiency, P magnetic resonance spectroscopy (MRS) was performed in 2 relatively severe anemic patients during forearm exercise while assessing the changes in phosphocreatine and inorganic phosphate. Peak VO2 and AT in non-athletes were significantly lower in IDA group than Nor group (peak VO2 (ml/min/kg): 23.7 +/- 5.1 vs 33.3 +/- 3.8, p less than 0.01, AT (ml/min/kg): 15.9 +/- 3.3 vs 21.3 +/- 1.3, p less than 0.01). After iron administration, Hgb was increased significantly in IDA group (from 9.0 +/- 1.8 to 12.1 +/- 0.8 g/dl, p less than 0.01) accompanied by an improvement in peak VO2 and AT (peak VO2 (ml/min/kg): from 34.2 +/- 12.4 to 40.0 + 13.0, p less than 0.001, AT (ml/min/kg): from 20.9 +/- 6.3 to 25.0 +/- 8.0, p less than 0.001). Lat-ID and Nor groups showed no changes. MRS indices of cell energy metabolism of the 2 severely anemic patients did not differ from those of normal controls, and no changes were observed after iron treatment. It is concluded from these results in iron deficiency anemia that oxygen transport is a determinant of anaerobic threshold.
无氧阈(AT)已被倡导作为评估慢性充血性心力衰竭患者运动能力的一种客观方法。然而,决定无氧阈的因素仍不清楚。为了评估氧运输能力对无氧阈的影响,对缺铁性贫血患者在补铁治疗前后进行了研究。研究了29名女性受试者。她们被分为以下3组:1)缺铁性贫血组(IDA组:血红蛋白低于11g/dl且铁蛋白低于10ng/ml),包括4名运动员和6名非运动员;2)潜在缺铁组(Lat-ID组:血红蛋白大于或等于11g/dl且铁蛋白低于10ng/ml),包括4名运动员;3)正常组(Nor组:血红蛋白大于或等于11g/dl且铁蛋白大于或等于10ng/ml),包括15名运动员和6名非运动员。通过采用斜坡方案的自行车测力计,测量了每组的峰值摄氧量(peak VO2)和无氧阈。在第一次运动测试后,IDA组和Lat-ID组口服铁剂治疗1 - 1.5个月。然后进行第二次运动测试。此外,为了研究缺铁是否会改变肌肉细胞能量代谢本身,在2名相对严重贫血的患者进行前臂运动时进行了磷磁共振波谱(MRS)检查,同时评估磷酸肌酸和无机磷酸盐的变化。IDA组非运动员的peak VO2和无氧阈显著低于Nor组(peak VO2(ml/min/kg):23.7±5.1 vs 33.3±3.8,p<0.01,无氧阈(ml/min/kg):15.9±3.3 vs 21.3±1.3,p<0.01)。补铁后,IDA组血红蛋白显著升高(从9.0±1.8升至12.1±0.8g/dl,p<0.01),同时peak VO2和无氧阈有所改善(peak VO2(ml/min/kg):从34.2±12.4升至40.0 + 13.0,p<0.001,无氧阈(ml/min/kg):从20.9±6.3升至25.0±8.0,p<0.001)。Lat-ID组和Nor组无变化。2名严重贫血患者的细胞能量代谢MRS指标与正常对照组无差异,补铁治疗后也未观察到变化。从缺铁性贫血的这些结果可以得出结论,氧运输是无氧阈的一个决定因素。